ISRCTN31378214已完成未知
Prognostic factors and early risk-adapted therapy in patients with chronic lymphocytic leukemia in Binet stage A
German CLL Study Group (GCLLSG) (Germany)0 个研究点目标入组 539 人开始时间: 2005年10月6日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 539
研究概览
简要总结
2020 results in https://www.ncbi.nlm.nih.gov/pubmed/32042081 (added 12/02/2020)
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Confirmed diagnosis of Chronic Lymphocytic Leukemia (CLL) in Binet stage A
- •2. Initial diagnosis within the last three years
- •3. No previous therapy
- •4. Age between 18 and 75 years
- •5. Eastern Cooperative Oncology Group (ECOG) status zero to two
- •6. Signed informed consent
排除标准
- •1. Autoimmune cytopenia
- •2. Severe concommitant disease
- •3. Concomitant secondary neoplasia
- •4. Participation in another clinical trial
研究者
相似试验
已完成
不适用
A diagnostic study comparing different tests for the diagnosis of COVID-19COVID-19 (SARS-CoV-2 infection)RespiratoryISRCTN13990999IRCCS Sacro Cuore Don Calabria hospital346
已完成
不适用
Evaluation of Groups for Alcohol-misusing Short-term PrisonersMental and behavioural disorders due to use of alcoholISRCTN68904585Abertawe Bro Morgannwg University Health Board (UK)238
进行中（未招募）
不适用
Pre-hospital identification of prognostic biomarkers in time-dependent diseasesISRCTN48326533Gerencia de Emergencias Sanitarias de Castilla y León1,114
已完成
3 期
Randomised phase III study on the effect of early intensification of rituximab in combination with two-weekly cyclophosphamide, doxorubicin, vincristine and prednisone (CHOP) chemotherapy followed by rituximab maintenance in elderly patients (66 to 80 years) with diffuse large B-cell lymphomaCancerISRCTN82286322Dutch Haemato-Oncology Association (Stichting Hemato-Oncologie Volwassenen Nederland) (HOVON) (The Netherlands) - Data Centre600
已完成
不适用
Pretreatment prognostic factors for predict survival outcome in advanced non small cell lung cancer with first line treatment in Thailand. A retrospective cohort studyFocus on Pretreatment Factors that possible effect to survivalPretreatment factors,survival,Non Small Cell Lung CancerTCTR20161219003Faculty of medicine,Chulalongkorn university310